Alliancebernstein L.P. Intercept Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

$275 Billion
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.99 - $18.71 $14.8 Million - $27.7 Million	1,482,206 Added 2442.26%	1,542,896 $28.6 Million
Q2 2023 Aug 15, 2023	SELL	$9.17 - $19.29 $882,887 - $1.86 Million	-96,280 Reduced 61.34%	60,690 $671,000
Q1 2023 May 15, 2023	BUY	$12.53 - $21.71 $1.57 Million - $2.71 Million	125,000 Added 390.99%	156,970 $2.11 Million
Q4 2022 Feb 14, 2023	BUY	$11.61 - $16.11 $88,236 - $122,436	7,600 Added 31.19%	31,970 $395,000
Q1 2022 May 13, 2022	SELL	$13.37 - $17.79 $846,040 - $1.13 Million	-63,279 Reduced 72.2%	24,370 $396,000

Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $903,624 - $1.24 Million	63,279 Added 259.66%	87,649 $1.43 Million
Q3 2021 Nov 10, 2021	SELL	$12.99 - $20.47 $103,920 - $163,760	-8,000 Reduced 24.71%	24,370 $362,000
Q2 2021 Jul 30, 2021	BUY	$15.46 - $24.5 $125,226 - $198,450	8,100 Added 33.37%	32,370 $646,000
Q1 2021 May 06, 2021	SELL	$19.33 - $37.75 $226,160 - $441,675	-11,700 Reduced 32.53%	24,270 $560,000
Q3 2020 Nov 12, 2020	SELL	$39.09 - $53.44 $35,181 - $48,096	-900 Reduced 2.44%	35,970 $1.49 Million
Q2 2020 Aug 13, 2020	BUY	$46.7 - $92.04 $23,350 - $46,020	500 Added 1.37%	36,870 $1.77 Million
Q4 2019 Feb 18, 2020	BUY	$57.36 - $124.1 $91,776 - $198,560	1,600 Added 4.6%	36,370 $4.51 Million
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $41,083 - $56,321	700 Added 2.05%	34,770 $2.31 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $326,634 - $506,856	4,200 Added 14.06%	34,070 $2.71 Million
Q1 2019 May 14, 2019	SELL	$91.83 - $120.68 $3.64 Million - $4.78 Million	-39,600 Reduced 57.0%	29,870 $3.34 Million
Q4 2018 Feb 13, 2019	BUY	$85.79 - $126.46 $3.17 Million - $4.67 Million	36,900 Added 113.29%	69,470 $7 Million
Q3 2018 Nov 08, 2018	SELL	$88.49 - $127.55 $6.19 Million - $8.93 Million	-70,000 Reduced 68.25%	32,570 $4.12 Million
Q2 2018 Aug 13, 2018	BUY	$60.0 - $85.67 $2.7 Million - $3.86 Million	45,056 Added 78.34%	102,570 $8.61 Million
Q1 2018 May 14, 2018	BUY	$52.72 - $67.25 $2.54 Million - $3.25 Million	48,255 Added 521.17%	57,514 $3.54 Million
Q4 2017 Feb 13, 2018	SELL	$58.2 - $72.76 $5,820 - $7,276	-100 Reduced 1.07%	9,259 $541,000
Q3 2017 Nov 13, 2017	BUY	$57.01 - $118.75 $533,556 - $1.11 Million	9,359	9,359 $543,000

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account